Tag: BrainGate

3 articles

Research

DARPA is funding non-invasive neuroplasticity technology

DARPA's Defense Sciences Office has posted Special Notice DARPA-SN-26-111 for its forthcoming SHINE (Selective Harnessing of Intrinsic Neuroplasticity Engineering) Disruption Opportunity, with a prerecorded Information Session webcast on 25 August 2026 and the DO release anticipated the same month. Program manager is Robin Bonomi. SHINE aims to non-invasively induce adaptive neuroplasticity in targeted dysfunctional neural circuits for injury recovery, spanning five modality domains. Awards will be Other Transactions for prototype projects. Registration closes 14 August 2026 and is unusually open to foreign nationals.

Aug 11

Industry News

Precision Neuroscience appoints John Donoghue as scientific advisor

On Thursday 23 July 2026, New York-based Precision Neuroscience announced the appointment of John Donoghue - founding investigator of the BrainGate consortium at Brown, co-founder of Cyberkinetics, and inaugural director of the Wyss Center for Bio and Neuroengineering in Geneva - as a scientific advisor to the company. Donoghue will advise Precision's scientific and engineering teams on device design, signal decoding, and clinical strategy. The appointment lands two days after Precision's non-paralysed cursor-control demonstration across its 15-plus academic-medical-centre clinical network, and at exactly the moment ABILITY Neurotech, the Wyss Center spin-out whose technology was conceived under Donoghue's own directorship, prepares to begin its own chronic first-in-human implantation in ALS patients.

Jul 25